CAS: 27591-69-1; 2,7-Bis(2-(Diethylamino)Ethoxy)-9H-Fluoren-9-One Dihydrochloride

该化合物是一种抗病毒化合物,主要以其免疫激素特性而闻名,被归类为干扰诱导剂,即刺激在病毒感染的免疫反应中发挥关键作用的蛋白质干扰剂的生产,Tirorone的特点是水溶性相对较低,可能影响其生物利用率和药用动力学;该物质通常通过口服施用,并研究其对抗各种病毒感染(包括流感和其他呼吸道病毒)的潜在效力;除了其抗病毒活动外,Tirorone还因其在治疗某些类型癌症方面的潜在用途而受到调查,因为其能够加强免疫反应;安全和功效简介是其使用中的基本考虑因素;必须指出,尽管Tirorone在实验室研究中显示出希望,但其临床应用可能因管制批准和正在进行的研究而有所不同;与任何制药化合物一样,了解其行动机制,副作用以及与其他药物的相互作用对于安全使用至关重要.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号27591-97-5 替洛隆 | CAS号869-24-9 2-二乙氨基氯乙烷盐酸盐 | CAS号100-37-8 二乙氨基乙醇 | CAS号67-63-0 异丙醇 | CAS号27591-97-5 替洛隆 | CAS号93418-47-4 2-[7-[2-(diethy...

合成工艺路线路线简述

  • 合成目标产物 Tilorone Dihydrochloride 主要起始原料 Tilorone
  • (文献来源)合成步骤主要原料 Tilorone
乙胺芴酮 在 盐酸体系中,用 乙醇作为反应溶剂,以200 G的收率获得tilorone DihydroChloride
参考文献:一种具有明显的ifn-α诱导活性的盐酸双氯隆的有效合成方法.
标题:一种具有明显的ifn-α诱导活性的盐酸双氯隆的有效合成方法.
摘要:盐酸噻氯隆(1)具有诱导干扰素抵抗病原体感染的巨大潜力.在本文中,我们描述了一种方便的制备2,7-二羟基芴-9-一(2)的方法,这是制备替洛龙二盐酸盐(1)的常用药物中间体.在该新方法中,在较温和的条件下以较高的收率进行了4,4'-二羟基-[1,1'-联苯]-2-羧酸的甲基酯化反应(4),这在化合物的制备中起着重要作用2.通过熔点,Ir,Ms和1 H-Nmr表征相关中间体和目标化合物的结构.此外,合成的盐酸氢吡咯酮在12 H内对小鼠干扰素-α(Ifn-α)的诱导具有明显的作用,直至24 H观察到峰值.
Doi:10.3390/Molecules201219781

海关参考信息

专利信息


专利号:US-2024409495-A1
优先权日:2021-10-20
标 题 :Process for the preparation of 2,7-dihydroxy-9-fluorenone useful for the synthesis of tilorone and its salts
发明人:JAISANKAR PARASURAMAN; DEB INDUBHUSAN; BHATTACHARJEE PINAKI
权利人:COUNCIL SCIENT IND RES
摘要:Methods involving preparation of building blocks of 2,7-dihydroxy-9-fluorenone toward the synthesis of tilorone dihydrochloride salt and other salts (bromide, iodide, fluoride, citrate, oxalate, maleate, phosphate, tartrate, triflate, trifluoroacetate, tetrafluoroborate) of tilorone, and an efficient, safe, cost effective method for the preparation of 2,7-bis-[2-(diethylamino)ethoxy]-fluorenone-9 and its various salts are developed. The methods involve oxygenation of fluorene, nitration of fluorenone, followed by reduction and diazotization toward the formation of 2,7-dihydroxy-9-fluorenone, which is the key intermediate for the formation of 2,7-bis-[2-(diethylamino)ethoxy]-9-fluorenone-dihydrochloride (Tilorone dihydrochloride) and other tilorone salts. The synthesis method has relatively simple operation, mild reaction conditions, high yield, and simple process with yields of 80-97%. Subsequent product purification of this method uses filtration and crystallization methods, avoiding the existing methods of column chromatography. Therefore, the research of its synthetic method being with a wide range of applications from the drug development and material synthesis point of view.

专利号:WO-2025076406-A1
优先权日:2023-10-05
标题:Synthesis and evaluation of 9-aminoacridines with sars-cov-2 antiviral activity
发明人:JONES THANE; LANE THOMAS; MAKAROV VADIM; EKLINS SEAN
权利人:COLLABORATIONS PHARMACEUTICALS INC
摘要:The synthesis and characterization of a series of derivatives and analogs based on the 9-aminoacridine scaffold shared by antimalarial drugs quinacrine and pyronaridine are described. Also described is the structure-activity relationship of these compounds against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease of 2019 (COVID-19). Several compounds displayed potent in vitro activity, with 50% inhibitory concentrations below 1 micromolar.

专利号:US-2009012088-A1
优先权日:2005-07-26
标 题:Compounds for the Treatment of Neurodegeneration and Stroke
发明人:HERGENROTHER PAUL J; PUTT KARSON S; LIU XIANJUN
权利人:HERGENROTHER PAUL J; PUTT KARSON S; LIU XIANJUN
摘要:Compounds and related methods for synthesis, and the use of compounds for the treatment of neurodegenerative diseases are disclosed. Compounds are disclosed in connection with PARG and/or PARP inhibition. Therapeutic applications are relevant for preventing or inhibiting neurological cell death for a variety of neurodegenerative conditions including Parkinson's disease, ischemia, and stroke. Also disclosed is a high-throughput screen for identifying compounds capable of inhibiting PARG and/or PARP.

专利号:WO-2023067624-A1
优先权日:2021-10-20
标 题 :A process for the preparation of 2,7-dihydroxy-9-fluorenone useful for the synthesis of tilorone and its salts

专利号:WO-2009056955-A1
优先权日:2007-10-30
标题 :Amine-bearing phospholipids (abps), their synthesis and use
发明人:ZUMBUEHL ANDREAS
权利人:UNIV BASEL; ZUMBUEHL ANDREAS
摘要:Disclosed herein are amine-bearing phospholipids (ABP). The ABPs display many properties and functionalities of naturally occurring phospholipids, but also new properties and functionalities, such as the ability to polymerize while maintaining structural integrity, that may supplement or expand the functionalities of naturally occurring phospholipids.

专利号:CN-118175999-A
优先权日:2021-10-20
标题 :Process for the preparation of 2, 7-dihydroxy-9-fluorenone useful for the synthesis of telulone and its salts
南京康瑞医药化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.legendpharm.com
电话: 25-8317486👤
📞南京康瑞医药化工有限公司 ⚠️参考联系方式

销售电话:25-8317486
邮箱:info@legendpharm.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
南京伊鹤田科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.ehfield.com
电话: 025 86551269👤
📞南京伊鹤田科技有限公司 ⚠️参考联系方式

销售电话:025 86551269
邮箱:info@ehfield.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
山东星顺新材料股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.sd-xingshun.com
企业联系电话:0519-86461196;86464994👤
📞山东星顺新材料股份有限公司 ⚠️参考联系方式
联系人:顾小星
电话:0519-86461196;86464994
手机:13809078067
传真:0519-86463703
邮箱:gxx@xingshengtech.com,gxy@xingshengtech.com
通信地址: 江苏省常州市武进区庙桥街
邮编: 213167
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省常州市武进区庙桥街
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Ekins S, Lingerfelt MA, Comer JE, Freiberg AN, Mirsalis JC, O'Loughlin K, Harutyunyan A, McFarlane C, Green CE, Madrid PB. Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection. Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01711-17. doi: 10.1128/AAC.01711-17. [Epub ahead of print] doi: 10.3390/molecules201219781. doi: 10.3892/or.2014.3174. Epub 2014 May 13.
4: Zholobak NM, Kavok NS, Bogorad-Kobelska OS, Borovoy IA, Malyukina MY, Spivak MY. Effect of tilorone and its analogues on the change of mitochondrial potential of rat hepatocytes. Fiziol Zh. 2012;58(2):39-43. Ukrainian. Russian. Int J Cancer. 1993 May 28;54(3):518-23.

合成参考文献


摘要:Pharmaceutical Chemistry Journal, 23(497), 1989
参考文献:10.1016/s0940-2993(11)80351-9
摘要:Pfau D, Westphal S, Bossanyi PV, Dietzmann K. Abnormal dendritic maturation of neurons under the influence of a Tilorone® analogue (R 10.874). Experimental and Toxicologic Pathology. 1995 Jan;47(5):367–74. doi: 10.1016/s0940-2993(11)80351-9.
参考文献:10.1111/j.1600-0773.1996.tb00252.x
摘要:Lüllmann-Rauch R, von Witzendorff B. Lysosomal storage of sulphated glycosaminoglycans induced by dicationic amphiphilic drug molecules: significance of the central planar ring system. Pharmacol Toxicol. 1996 Sep;79(3):109–13. doi: 10.1111/j.1600-0773.1996.tb00252.x.
摘要:Zholobak NM, Mandzhos AP, Verevka SV, Povodzinskiĭ VM, Karpov AV. [Interferonogenic activity of immobilized ribopolynucleotides in vitro]. Ukr Biokhim Zh (1999). 2003 Nov;75(6):106–10.
摘要:Tkachenko IV, Garkavaia EG, Karpov AV. [Allergenic and immunotropic properties of yeast RNA-tilorone hydrochloride molecular complex]. Zh Mikrobiol Epidemiol Immunobiol. 2006 Mar;(2):70–4.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知